Mol Interv. 2009 Apr;9(2):70-4.
Anti-HIV-1 therapeutics: from FDA-approved drugs to hypothetical future targets.
Adamson CS, Freed EO.
Virus-Cell Interaction Section, HIV Drug Resistance Program, National Cancer Institute at Frederick, Maryland, 21702-1201, USA. cadamson@ncifcrf.gov
PMID: 19401538 [PubMed - indexed for MEDLINE]
Full Text Sources:
Other Literature Sources:
Medical: